Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Amanda Bronstad | May 15, 2017
Securities lawsuits have become a major headache for life sciences companies, according to recent reports. And two plaintiffs' firms, Pomerantz and The Rosen Law Firm, are leading the charge.
1 minute read
By Zack Needles | May 11, 2017
A 12-member Philadelphia jury handed up a $20 million verdict—including $17.5 million in punitive damages—against Johnson & Johnson subsidiary Ethicon in the third pelvic mesh case to go to trial in the city.
1 minute read
By Amanda Bronstad | May 4, 2017
A federal jury in New Orleans deliberated for less than two hours before coming back this week with a defense win in the first bellwether trial over the blood thinner Xarelto. That's a bona fide slam dunk--even for lead defense counsel Beth Wilkinson, who's notched a streak of trial victories in her career.
1 minute read
By Jason Grant | May 4, 2017
New York University's breach of contract lawsuit against Pfizer over hundreds of millions of dollars in cancer drug royalties must go forward, a divided Manhattan appeals court has ruled.
1 minute read
By Charles Toutant | May 3, 2017
AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
1 minute read
By Amanda Bronstad | May 3, 2017
Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
1 minute read
By Charles Toutant | May 2, 2017
A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
1 minute read
By P.J. D'Annunzio | May 2, 2017
A group of 485 independently owned pharmacies nationwide has sued OptumRx, the successor company to Catamaran Corp. through a merger, claiming they were low-balled on reimbursements based on outdated pricing data.
1 minute read
By Max Mitchell | May 1, 2017
Three weeks before the latest Risperdal case was tossed out midtrial, one of the jurors initially tasked with evaluating the claims collapsed while a plaintiff's expert was testifying on the stand.
1 minute read
By Scott Graham | May 1, 2017
The U.S. Court of Appeals for the Federal Circuit ruled a drug used to treat chemotherapy symptoms did not avoid the on-sale bar for patents despite keeping some details of its drug sale confidential.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS